Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 176,032 | 220,449 | 185,922 | 340,238 | 316,065 |
| Marketable Securities | 561,794 | 521,866 | 500,371 | 402,840 | 401,182 |
| TOTAL | $754,535 | $764,600 | $713,151 | $770,380 | $746,888 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 15 |
| Investments And Advances | 250,490 | 343,931 | 442,003 | 54,751 | 69,824 |
| Other Non-Current Assets | 552 | 621 | 689 | 755 | 820 |
| TOTAL | $251,042 | $344,552 | $442,692 | $55,506 | $70,659 |
| Total Assets | $1,005,577 | $1,109,152 | $1,155,843 | $825,886 | $817,547 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,399 | 13,249 | 10,831 | 9,027 | 25,223 |
| Accrued Expenses | 27,252 | 33,651 | 24,944 | 30,727 | 18,068 |
| TOTAL | $47,651 | $60,401 | $42,439 | $39,754 | $43,291 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 22,560 | 29,107 | 35,491 | 35,326 |
| Other Non-Current Liabilities | 289 | 372 | 451 | 529 | 605 |
| TOTAL | $289 | $22,932 | $29,558 | $36,020 | $35,931 |
| Total Liabilities | $47,940 | $83,333 | $71,997 | $75,774 | $79,222 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,316 | 79,989 | 79,718 | 79,620 | 69,799 |
| Common Shares | 8 | 8 | 8 | 7 | 7 |
| Retained earnings | -1,048,952 | -967,386 | -896,881 | -826,156 | -756,132 |
| Other shareholders' equity | 1,826 | 988 | 1,085 | 948 | 2,103 |
| TOTAL | $957,637 | $1,025,819 | $1,083,846 | $750,112 | $738,325 |
| Total Liabilities And Equity | $1,005,577 | $1,109,152 | $1,155,843 | $825,886 | $817,547 |